FDA Turnover, Kennedy Ruling & Health News Roundup – March 20, 2026

Good morning and happy Friday. The health policy landscape continues to evolve rapidly, with key discussions unfolding at this week’s Breakthrough Summit East. Among the most notable moments was a pointed exchange regarding the challenges facing the Food and Drug Administration (FDA), and a judge’s forthcoming ruling on gender-affirming care declarations.

The FDA’s Turnover Troubles

A significant focus at the summit centered on the high rate of turnover and reported discontent within the FDA. During a session, STAT News’s Lizzy Lawrence directly questioned Medicare Director Chris Klomp about the agency’s struggles. The resulting silence, reportedly lasting several seconds, underscored the gravity of the situation. Klomp eventually acknowledged the importance of cultivating talent and building strong teams, recognizing that these processes accept time. Further details on Klomp’s comments regarding drug pricing and Medicare Advantage are available from STAT News.

The concerns extend beyond simple staffing changes. As Lizzy Lawrence reported in March 2026, the Center for Drug Evaluation and Research (CDER) alone experienced five director changes in 2025. Lawrence’s reporting highlights the difficulties in maintaining consistent coverage due to limited access to FDA officials, a situation exacerbated by staffing cuts in the public information office. Stelios Papadopoulos, chairman of Exelixis, offered a stark assessment, suggesting that if the FDA were a company, investors would be selling its stock. He also praised Klomp, calling him “amazing” and “my hero.” Robert Califf, a former FDA commissioner, echoed this sentiment, stating he would “go to work for that guy.”

Gender-Affirming Care and Legal Challenges

In a separate development, a U.S. District judge in Oregon has indicated he will overturn a declaration issued in December 2025 by Health Secretary Robert F. Kennedy Jr. This declaration asserted that gender-affirming care for young transgender individuals does not meet established medical standards. Judge Mustafa T. Kasubhai stated the declaration was “no mere opinion” and exceeded Kennedy’s authority, as regulation of medicine is primarily a state responsibility and federal rules require public notice and comment periods. More details on the arguments presented and the judge’s reasoning can be found in STAT News.

Addressing Pain in IUD Insertion

The conversation at the summit also touched on patient experience and pain management. OB-GYN Maryl Sackeim emphasized the growing awareness of pain associated with procedures like IUD insertion and a desire among physicians to address it more effectively. Sackeim, drawing on her own experiences as a patient, highlights the importance of acknowledging and mitigating pain during gynecological procedures. Her First Opinion essay details approaches to pain management and empowering patients.

Navigating Global Competition and Tobacco Subsidies

The summit also addressed broader issues of global competitiveness, particularly in relation to China. Michel Sadelain, director of the Columbia Initiative in Cell Engineering and Therapy, argued for adapting the U.S. System to restore its competitive edge. Meanwhile, a proposed amendment to the 2026 farm bill has raised concerns about potentially subsidizing tobacco farmers, despite the MAHA (Moving America’s Health Ahead) goal of reducing chronic disease rates. Kelsey Romeo-Stuppy, a nonprofit attorney, pointed out that this amendment would effectively subsidize a product responsible for approximately half a million deaths annually in the U.S. STAT News provides further coverage of this issue, noting it represents a win for the tobacco industry, which has seen favorable developments under the current administration.

Alcohol and Cancer Risk Awareness

Public awareness of the link between alcohol consumption and cancer risk appears to be growing. The Annenberg Public Policy Center reported that over half of Americans recognized this connection in February 2026, a significant increase from September 2024. This rise in awareness coincides with U.S. Surgeon General Vivek Murthy’s call for updated warning labels on alcohol products to highlight the increased risk of at least seven types of cancer. The Annenberg Public Policy Center’s report details these findings.

Diet, Genetics, and Alzheimer’s Risk

Recent research published in JAMA Network Open explored the relationship between meat consumption and Alzheimer’s risk. The study, involving over 2,100 Swedish residents, found that for individuals with specific gene variations (APOE 3/4 and 4/4) that increase Alzheimer’s risk, higher meat intake was associated with better cognitive outcomes. However, this association was not observed in individuals without these gene variations. Researchers caution that this is an observational study and further research is needed to understand the complex interplay between diet and brain health. The study’s findings suggest that dietary recommendations may need to be tailored to individual genetic profiles.

Ongoing Developments to Watch

Several other stories are currently garnering attention. Wired is reporting on the legal battles to hold AI companies accountable for children’s deaths, whereas The 19th highlights efforts to raise awareness about HIV care access. STAT News also covers the organization of an independent autism committee to counter the influence of advisors to Robert F. Kennedy Jr., and the impact of legislative actions on Planned Parenthood services. Finally, STAT News examines the need to address issues within the No Surprises Act to prevent financial burdens on patients and employers.

Looking for a mental workout? Endeavor your hand at today’s STAT Mini crossword.